Francesco Cusano

Benevento, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Management of severe dysplastic nevus (high-grade dysplasia): Italian recommendations for good clinical practice.

Management of severe dysplastic nevus (high-grade dysplasia): Italian recommendations for good clinical practice.

Journal: Dermatology reports

Published: November 08, 2025

Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis).

Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis).

Journal: Clinical drug investigation

Published: April 08, 2025

Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis).

Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis).

Journal: Dermatology and therapy

Published: March 10, 2025

Call for regulation of social media health content: an initiative of the Italian Association of Hospital Dermatologists (ADOI).

Call for regulation of social media health content: an initiative of the Italian Association of Hospital Dermatologists (ADOI).

Journal: Dermatology reports

Published: October 15, 2024

A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient?

A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient?

Journal: Dermatology practical & conceptual

Published: September 25, 2024

The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).

The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).

Journal: Clinical and experimental dermatology

Published: September 15, 2024

Lack of communication between dermatologists and histopathologists in real-life settings: a survey of the Italian Association of Hospital Dermatologists (ADOI).

Lack of communication between dermatologists and histopathologists in real-life settings: a survey of the Italian Association of Hospital Dermatologists (ADOI).

Journal: Dermatology reports

Published: July 10, 2024

Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA).

Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA).

Journal: Italian journal of dermatology and venereology

Published: May 10, 2024

Italian S3-Guideline on the treatment of Atopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).

Italian S3-Guideline on the treatment of Atopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).

Journal: Italian journal of dermatology and venereology

Published: May 10, 2024

Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).

Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA).

Journal: Italian journal of dermatology and venereology

Published: May 10, 2024

Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study.

Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real-world study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 29, 2024

Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis).

Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis).

Journal: Dermatology practical & conceptual

Published: February 23, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026